Purpose: The purpose of the present study was to measure the effect of fatigue in quality of life by measuring self-perceived health in patients with thalassemia. Methods: 302 patients undergoing transfusion treatment from 5 hospitals around Greece participated in the study. Fatigue was measured with open access questions and quality of life with the Euro5D thermometer as self-perceived health. Statistical analysis was performed with SPSS21. Results: 236 patients (78.7%) reported that they were suffering from fatigue while only 21.3 % (n=66) reported that they had no fatigue. Present health status had a mean of 69.9 with an SD 19.3. Almost half (48.2%) declared they had fatigue a few times over a months period, while 41.7% replied that daily activities were the cause for feeling fatigue. Females reported statistically significant higher existence of fatigue (x2= 5.744; p=0.017). Education and marital status had no correlation with self-perceived health. Existence, frequency of fatigue, existence of fatigue during the last month, self-interpretation of the cause of fatigue and frequency of fatigue before transfusion all had significant differences with self-perceived health (p<0.05). Conclusions: Fatigue has been identified as a very common symptom in patients with thalassemia affecting the self-perceived health in this population. This result broadens the evidence regarding fatigue in hemoglobinopathies and leads us to the need for distinguishing the etiologies leading to fatigue in hemoglobinopathies since it is an important factor affecting HPQoL. Longitudinal studies are needed in order to understand the path of fatigue and the factors influencing the condition.
INTRODUCTION
Health related quality of life (HRQoL) has been defined from Patrick and Erickson as the value allocated to duration of life as it is modified by the functional states, impairments, perceptions and social opportunities that are inclined by disease, injury, treatment or policy. 1 One of the main topics in HRQoL includes patients' evaluation of their current level of functioning, as well as satisfaction with it, related to what they consider to be ideal. Under this spectrum, one of the significant aspects in HRQoL study is how the expression of an illness or treatment is experienced by an individual. 2 Thalassemia is an inherited blood disease. It consists a serious public health problem throughout the Mediterranean region, Middle East, and Indian subcontinent, as well as in Southeast Asia 3 and as a chronic disease affects the HRQoL of individuals.
Fatigue, on the other hand, is a symptom with subjective significance and major consequence in an individual's life and Health Related Quality of Life (HRQoL). Many definitions have been used in order to describe fatigue, something that makes the identification of the symptom more difficult, as only few differentiating factors between causes exist, as well as taxation indicators regarding the effect of fatigue in human beings. 4, 5 Considerably, fatigue is mostly defined as a subjective symptom or as an objective reduction in an individual's everyday activity. 6 Literature distinguishes fatigue as a symptom that is mostly complex and multifactorial, 7, 8 as it comprises of bodily and emotional factors, as well as occupational and life events. [8] [9] [10] In patients with hemoglobinopathies fatigue has been identified as a major symptom affecting both health and quality of life in patients with sickle cell disease while it has been found that fatigue was a major symptom affecting the quality of life in patients with thalassemia major as well, 11 but there is no study exploring the characteristics of fatigue in Thalassemia major patients and the correlation between the symptom and the health status of the patients.
The purpose of the present study was to investigate the symptom of fatigue in patients with hemoglobinopathies under transfusion therapy and its correlation with the self-evaluation of the present health of patients by measuring self-perceived health.
MATERIAL AND METHODS

Patients and settings
This is a descriptive study, which was conducted in 2 central hospitals in the rural area of Athens and 3 hospitals in the urban areas of Karditsa, Chania and Arta in Greece and lasted from February 2017 to April 2018. The study sample consisted of 302 patients undergoing transfusion treatment.
Data collection was conducted only after having been granted the Ethical Approval from University of Peloponnesus and the ethics committees of the hospitals that their patients participated in the study. Individuals taking part in this research were clearly informed of the voluntary nature of their participation and their right to quit the study at any point they wish so and that study results would be confidential.
A written informed consent was also obtained from all participants before the completion of the questionnaires that were used in the study. In order for a patient to be included in the study he or she should be a chronic patient under transfusion treatment for at least one year, to have a diagnosis of hemoglobinopathy (Thalassaemia major or minor, Sickle cell disease or sickle-beta thalassaemia), and to have the ability to speak and understand the Greek language. Exclusion criteria were to suffer from a psychiatric disease or serious cognitive impairment.
Data collection
To measure fatigue, a questionnaire was created with close answer 
RESULTS
Sample characteristics
The studied sample consisted of 172 females (57.1%) and 130 males Finally present health status had a mean of 69.9 with a SD 19.3, with minimum value 10 and maximum 100.
Characteristics of fatigue
The majority of patients (78.7%) reported that they were suffering from fatigue (n=236) while only 21.3 % (n=66) reported that they had no fatigue.
In relation to the frequency with which participants experienced fatigue, out of the 247 participants who answered the question, 7.3% said fatigue is a common symptom, 23.1% is experiencing fatigue often during the week , 20.6% said they had fatigue one to two days a week and almost half (48.2%) said they had fatigue a few times over a months period.
In the question of what is thought to be the cause of fatigue, out of the 218 patients who answered, the largest percentage of respondents (41.7%) replied that daily activities were the cause for feeling fatigue, only 8.3% of them answered that fatigue is the result of their occupation, while, 12.4% said that fatigue was caused by their emotional state and, above all, the existence of depressed mood. Finally, the rest 17.9% of the sample linked the fatigue to the transfusion.
Regarding the onset of fatigue before transfusion, a large percentage of participants (N = 129-55.6%) replied that fatigue occurred less than a week before the scheduled transfusion, 9.9% that the onset of fatigue was from 6 days to 2 weeks before the transfusion, another 9.5% between 2 weeks to 1 month, while 25% said they had no fatigue before the transfusion.
In relation to the incidence of fatigue during the last month before the participation in the study, 6 .4% said that they suffered from fatigue on a daily basis, 16.7% most days of the month, 16.7% fewer than half the days of the month, while 32.6% said that they had rarely experienced fatigue in the last month. Regarding the correlation between Self-perceived health as it was measured with the Euro5D and the demographic variables, independent sample t test did not manage to reveal any significant differences between rural and urban residences (t=0.017 p>0.05) or between males and females (t=0.460 p>0.05) in Self-perceived health. (Table   3) Finally, one way analysis of variance ANOVA, which was used to identify significant differences in Self-perceived health between the four different marital status categories and the five different education categories of the sample, revealed that no significant overall differences were existing as F=0.221, p>0.05 and F=1.783, p>0.05 respectively. (Table 3 )
Differences between demographic variables with
Correlation between fatigue characteristics and Self-perceived health
In order to explore significant differences in Self-perceived health between the patients that were suffering from fatigue and those that didn't have fatigue, independent sample t test was used. Analysis revealed that those that had fatigue had statistically significant lower Self-perceived health than those that had no fatigue (t=3.420 p<0.001). (Table 4) Finally, one way analysis of variance ANOVA was also used to identify significant differences in the present Self-perceived health between the four different variables describing fatigue. Analysis showed significant overall differences in how often a patient was experiencing fa- 
DISCUSSION
This was one of the first studies exploring the symptom of fatigue in regard to HRQoL in thalassemia major patients, since until now most of the published research concerns fatigue in patients with sickle cell disease. [13] [14] [15] [16] Only in one study fatigue was measured as a symptom of fibromyalgia in patients with thalassemia minor using 40 patients where they detected an increased prevalence of fatigue in those patients. 16 Our results reveal that in the majority of patients (almost 80%) with Thalassemia major and minor, under transfusion treatment are suffering from fatigue. This is a very interesting finding since until now fatigue was mainly found in with patients with iron deficiency anemia 17.18 and sickle cell anemia 13-16 but had not been explored in Thalassemia patients, since in the one study that fatigue was examined as a symptom, it was connected with pain and reduced quality of life and not as a unique symptom. 13 In relation to the frequency with which participants experienced fatigue, almost half of the sample reported that they experienced fatigue a few times over a month's period and one quarter of the patients reported that they were experiencing fatigue often during the week. Slightly lower was the amount of patients that reported they were suffering from fatigue one to two days through the week, while the rest 7.3% reported that fatigue was a common symptom in their lives.
Trying to identify the patient's beliefs about the cause of fatigue, a very large number of patients reported that daily activities were the cause for feeling fatigue. The second most important factor was not having been transfused, something that connects fatigue with low hemoglobin, a result that is consistent with other reports in the literature, 17 since fatigue is universally considered a key symptom of anemia, for example, in cancer. 19, 20 The third factor causing fatigue was emotional status, with the existence of depressing symptoms.
This finding was expected as well since there is extensive evidence of a significant relationship between depression and fatigue in chronic illnesses. [21] [22] [23] Finally, 8.3% of them answered that fatigue was the result of their occupation, a result which is consistent with literature about job fatigue. 24 Regarding the onset of fatigue before transfusion, more than half of the participants replied that fatigue occurred in a time less than a week before the scheduled transfusion, almost 10% that the onset of fatigue was from 6 days to 2 weeks before the transfusion, another 10% between 2 weeks to 1 month, while one out of five patients reported that they had no fatigue before the transfusion. Once again these results are consistent with the literature connecting fatigue with anemia and low hemoglobin like the one by Ameringer and colleagues who reported that lower levels of hemoglobin were significantly correlated with higher levels of fatigue, 14 even though results are controversial in this matter and more research is needed in order to explore all possible factors contributing to this correlation. 13 In relation to the incidence of fatigue during the last month before the participation in the study, 6.4% of the patients reported that they suffered from fatigue on a daily basis, 16.7% most days of the month, 16 .7% fewer than half the days of the month, while 32.6% said that they had rarely experienced fatigue in the last month. These results indicate that almost one in five patients are living with fatigue leading to reduced health and quality of life since fatigue has been found to be a factor affecting quality of life. 14 Considering gender differences, females reported statistically significantly higher existence of fatigue compared to males, result that is similar to other reports concerning hemoglobinopathy patients. 14 Regarding the correlation between health status and demographic variables, Independent sample t-test found no significant difference between rural and urban residence or between males and females in health status as expected since health status is correlated with the disease severity which is not affected by demographic variables or gender. 13, 14 No differences were found in the present health status between the four different marital status categories and the five different education categories of the sample as well, result that is consistent with previous results in Greece. 11 Our results concerning the correlation between fatigue and the self- 
Limitations
There are a number of limitations to our study. First of all, the participants in our study were recruited to represent a convenience sample of patients undertaking transfusion therapy which excluded the majority of patients with sickle cell disease that are not transfused. Thus, our sample was not a probability sample and findings cannot be generalized to the broader hemoglobinopathies population. This selection strategy and the correlational nature of the study design possible reduced our ability to identify any differences associated with the different diagnosis of hemoglobinopathies but give us robust evidence about Thalassemia major and minor patients in Greece. 
